Quick Answer
GRI Bio, Inc. reported Common Stock Shares Outstanding of 497,693 shares for the year ending 2025.
- GRI Bio, Inc. showed an increase of +2,551.8% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from GRI Bio, Inc.'s annual report (Form 10-K), filed with the SEC on January 30, 2026.
- XBRL data for this metric is available from 2020 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: 6.81 million shares | Q2 2021: 4.51 million shares | Q3 2021: 6.81 million shares | Q1 2022: 6.81 million shares | Q2 2022: 6.81 million shares | Q3 2022: 12.73 million shares | Q1 2023: 449,408 shares | Q2 2023: 422,333 shares | Q2 2023: 2.96 million shares | Q3 2023: 2.96 million shares | Q1 2024: 3.20 million shares | Q2 2024: 801,914 shares | Q3 2024: 5.02 million shares | Q1 2025: 525,358 shares | Q2 2025: 2.50 million shares | Q3 2025: 3.27 million shares.
- Over the full 7 years of available data (2020 to 2025), GRI Bio, Inc.'s Common Stock Shares Outstanding has declined by 89.0%.
- Historical annual values: Fiscal year 2025: 497,693 shares | Fiscal year 2024: 18,768 shares | Fiscal year 2023: 2,909 shares | Fiscal year 2023: 422,333 shares | Fiscal year 2022: 142,820 shares | Fiscal year 2021: 6.81 million shares | Fiscal year 2020: 4.51 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: